BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 9669168)

  • 21. Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs.
    Sohnle PG; Frank MM; Kirkpatrick CH
    J Immunol; 1976 Aug; 117(2):523-30. PubMed ID: 781132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Candida albicans delayed-type hypersensitivity (DTH) model in the female B₆C₃F₁ mouse for use in immunotoxicological investigations.
    White KL; McLoughlin CE; Auttachoat W; Smith MJ
    J Immunotoxicol; 2012; 9(2):141-7. PubMed ID: 22339419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on stimulation of cell-mediated cytotoxicity by skin test antigens. I. Candida antigen stimulation of cell-mediated cytotoxicity in vitro correlated with the skin test response to candida antigen in vivo.
    Tartof D; Check IJ; Matutis A; Hunter RL; Fitch FW
    J Immunol; 1980 Dec; 125(6):2790-6. PubMed ID: 6159422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine transfer factor. II. Transfer of delayed hypersensitivity to synthetic antigens.
    Kirkpatrick CH; Rozzo SJ; Mascali JJ; Merryman CF
    J Immunol; 1985 Mar; 134(3):1723-7. PubMed ID: 2578518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed hypersensitivity and transfer factor in experimental coccidioidomycosis.
    Likholetov SM
    Sabouraudia; 1979 Sep; 17(3):251-9. PubMed ID: 93786
    [No Abstract]   [Full Text] [Related]  

  • 27. Transfer of cell-mediated immunity to Paracoccidioides brasiliensis in hamsters with dialysable leukocyte extracts.
    Peraçoli MT; Montenegro MR; Soares AM; Mota NG
    J Med Vet Mycol; 1990; 28(1):35-46. PubMed ID: 1694543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 29. [Poliovirus-induced immunosuppression in mice and the possibilities for its correction].
    Shirobokov VP; Giulling EV; Korniushenko ON; Negrebetskaia EN; Rozenfel'd OL
    Mikrobiol Zh (1978); 1986; 48(1):86-90. PubMed ID: 2855844
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of antigen dose on the course of experimental mycogenic sensitization].
    Sardyko NV
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):75-9. PubMed ID: 7001816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunodeficiencies in chronic muco-cutaneous candidosis.
    Lehner T; Wilton JM; Ivanyi L
    Immunology; 1972 May; 22(5):775-87. PubMed ID: 4336639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of leukocyte migration by the agarose plate technique. Application to antigen from Candida albicans and Fusobacterium nucleatum.
    Budtz-Jorgensen E
    Acta Allergol; 1977 Feb; 32(1):15-26. PubMed ID: 320806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of adjuvants with Leishmania antigens in a guinea pig model to induce delayed-type hypersensitivity responses.
    Briand EJ; Ruble GR; Stiteler J; Harris LD; Burge JR; Soranaka ET; Glenn G; Quance-Fitch F; Rowton ED
    Lab Anim Sci; 1999 Oct; 49(5):519-21. PubMed ID: 10551453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of normal and abnormal delayed hypersensitivity to Candida albicans. Importance of evaluating lymphocyte activation by flow cytometry].
    Brunet JL; Peyramond D; Cozon GJ
    Allerg Immunol (Paris); 2001 Mar; 33(3):115-9. PubMed ID: 11386125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defect internalization and tyrosine kinase activation in Aire deficient antigen presenting cells exposed to Candida albicans antigens.
    Brännström J; Hässler S; Peltonen L; Herrmann B; Winqvist O
    Clin Immunol; 2006 Dec; 121(3):265-73. PubMed ID: 16982213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine transfer factors: dose-response relationships and routes of administration.
    Kirkpatrick CH; Hamad AR; Morton LC
    Cell Immunol; 1995 Sep; 164(2):203-6. PubMed ID: 7656328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody to ovalbumin and delayed-type hypersensitivity to Candida albicans and mycobacteria in lactating Holstein cows using Quil A or Freund's complete adjuvant.
    Heriazon A; Thompson KA; Wilkie BN; Mathes-Sears W; Quinton M; Mallard BA
    Vet Immunol Immunopathol; 2009 Feb; 127(3-4):220-7. PubMed ID: 19054579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced macrophage tumoricidal activity and tumor suppression or regression caused by heat-killed Candida albicans.
    Weinberg JB; Hibbs JB
    J Natl Cancer Inst; 1979 Nov; 63(5):1273-8. PubMed ID: 388016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo and in vitro evaluation of cell-mediated immunity in patients with paracoccidiodomycosis.
    Musatti CC; Rezkallah MT; Mendes E; Mendes NF
    Cell Immunol; 1976 Jun; 24(2):365-78. PubMed ID: 779977
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.